ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 221 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2021. The put-call ratio across all filers is 4.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,793 | +41.4% | 9,269 | +35.8% | 0.00% | – |
| Q2 2023 | $86,108 | +66.9% | 6,825 | +72.4% | 0.00% | – |
| Q1 2023 | $51,602 | -39.6% | 3,959 | -18.1% | 0.00% | – |
| Q4 2022 | $85,369 | +35.5% | 4,833 | +15.6% | 0.00% | – |
| Q3 2022 | $63,000 | +50.0% | 4,182 | +46.5% | 0.00% | – |
| Q2 2022 | $42,000 | -96.0% | 2,854 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $1,038,000 | +2156.5% | 46,128 | +1734.1% | 0.00% | – |
| Q4 2021 | $46,000 | +48.4% | 2,515 | +7.8% | 0.00% | – |
| Q3 2021 | $31,000 | -42.6% | 2,334 | -20.2% | 0.00% | – |
| Q2 2021 | $54,000 | +38.5% | 2,923 | +10.5% | 0.00% | – |
| Q1 2021 | $39,000 | +5.4% | 2,646 | 0.0% | 0.00% | – |
| Q4 2020 | $37,000 | -7.5% | 2,646 | -47.9% | 0.00% | – |
| Q3 2020 | $40,000 | +29.0% | 5,076 | +7.8% | 0.00% | – |
| Q2 2020 | $31,000 | -8.8% | 4,709 | -3.2% | 0.00% | – |
| Q1 2020 | $34,000 | – | 4,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |